Tag: Monsanto

A Supreme Court fight over Roundup warning labels could determine whether injured Americans can continue challenging pesticide manufacturers in court, while raising far-reaching questions about federal power, corporate liability, and public health protections.

A move by the administration aligns federal power with pesticide manufacturers as thousands of cancer patients fight for their day in court.

Several lawsuits were initiated in response to President Andrés Manuel López Obrador 2020 presidential decree, which aimed to ban glyphosate and genetically modified (GM) corn for human consumption.

A $185 million verdict against Pharmacia—a Monsanto spinoff—which sold now-banned chemicals called polychlorinated biphenyls (PCBs), was found liable in 2021 for chemical contamination.

John McKivison sued Bayer because he believes he developed cancer after using Roundup on his property for two decades,

Unveiling the controversy: a deep dive into the legal, scientific, and humanitarian debate over glyphosate's future

A “significant further decline” of glyphosate sales could push Bayer towards a breakup of its agriculture business.

Glyphosate was listed as a probable human carcinogen by the World Health Organization’s International Agency for Research on Cancer in 2015. 

Bayer said it plans to replace glyphosate-based weed-killing ingredients in products for non-professionals in the U.S. with alternative active ingredients in order to “manage litigation risk in the U.S.,” but not due to concerns about safety.

Monsanto owner, Bayer AG, is contemplating pulling the popular herbicide from the residential market as it struggles to cement a strategy to limit ongoing litigation.